CG Oncology (CGON) Assets Average (2024 - 2026)

CG Oncology's Assets Average history runs 3 years deep, the most recent figure standing at $963.4 million for Q1 2026.

• Quarterly Assets Average rose 29.93% year-over-year to $963.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $963.4 million (up 29.93% YoY) and the FY2025 annual result came in at $773.2 million, up 62.08% from the prior year.
• Assets Average was $963.4 million for Q1 2026 at CG Oncology, up from $760.8 million in the prior quarter.
• Across five years, Assets Average topped out at $963.4 million in Q1 2026 and bottomed at $389.2 million in Q1 2024.
• A 3-year average of $674.3 million and a median of $714.8 million in 2025 frame the typical range for Assets Average.
• Peak annual rise in Assets Average reached 90.51% in 2025, while the deepest fall reached 16.39% in 2025.
• CG Oncology's Assets Average stood at $653.6 million in 2024, then advanced by 16.39% to $760.8 million in 2025, then grew by 26.64% to $963.4 million in 2026.
• Business Quant data shows CGON's Assets Average at $963.4 million in Q1 2026, $760.8 million in Q4 2025, and $715.7 million in Q3 2025.